Ekso Bionics (NASDAQ:EKSO – Get Rating) had its target price cut by HC Wainwright from $11.00 to $9.00 in a research report report published on Friday, The Fly reports. They currently have a buy rating on the stock.
Separately, StockNews.com began coverage on shares of Ekso Bionics in a research report on Sunday, July 24th. They set a sell rating for the company.
Ekso Bionics Stock Down 0.6 %
Shares of Ekso Bionics stock opened at $1.75 on Friday. The company has a quick ratio of 7.48, a current ratio of 8.16 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $22.48 million, a PE ratio of -1.77 and a beta of 1.94. Ekso Bionics has a 12-month low of $1.54 and a 12-month high of $5.41. The stock’s fifty day moving average is $1.79 and its 200-day moving average is $2.24.
Institutional Investors Weigh In On Ekso Bionics
A hedge fund recently bought a new stake in Ekso Bionics stock. Golden State Wealth Management LLC purchased a new stake in shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 15,605 shares of the company’s stock, valued at approximately $41,000. Golden State Wealth Management LLC owned 0.12% of Ekso Bionics as of its most recent filing with the Securities & Exchange Commission. 14.65% of the stock is owned by institutional investors and hedge funds.
Ekso Bionics Company Profile
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
- Get a free copy of the StockNews.com research report on Ekso Bionics (EKSO)
- MarketBeat Podcast: Find Investing Opportunities For The Rest of 2022
- The Colgate-Palmolive Growth Outlook Brightens
- Deep Value High Yield Newell Brands Is Ready To Bottom
- These Stocks Outperformed Last Time There Was A Recession
- Does Rivian’s Stock Still Have A Future?
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.